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1. Introduction 
Regulation of citric acid cycle flwr through a 
direct allosteric inhibition of citrate synthase by 
ATP has been postulated by Hathaway and Atkinson 
[ 1 ] and by Shepherd and Garland [2] . Experimen- 
tal support for this conclusion was provided by Gar- 
land et al. [3,4] in studies with isolated rat liver 
mitochondria. However, doubts concerning a direct 
involvement of ATP in the physiological regulation 
of citrate synthase arose from the demonstration 
that inhibition by ATP in kinetic experiments could 
be reversed by Mg2+ [S] , and from mitochondrial 
studies of other workers which supported an indi- 
rect regulation by ATP via the effect of the NADH/ 
NAD ratio on oxalacetate availability [6- 111. More 
recent experiments, which examined control of the 
citric acid cycle in the absence of inhibitors, support- 
ed the existence of a feedback control between sub- 
strate-level phosphorylation at succinic thiokinase, 
effective only at high oxalacetate and low acetyl-CoA 
concentrations, and fhtx through citrate synthase 
[ 12, 131. Under these conditions, citrate synthase 
flux showed an inverse correlation with the measured 
succinyl-CoA content of the mitochondria, raising 
the possibility of direct inhibition of citrate synthase 
by succinyl-CoA. The kinetic experiments reported 
here with purified citrate synthase from beef heart 
and rat liver show that succinylCoA is a much stronger 
inhibitor of citrate production than ATP, strictly 
competitive with acetyl-CoA and noncompetitive 
with respect to oxalacetate. Furthermore, carefully 
controlled rate measurements how no kinetic indi- 
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cation of cooperativity in the presence or absence of 
either ATP or succinyl-CoA. Citrate, propionyl-CoA 
and CoA are also specific inhibitors at concentrations 
of physiological significance. 
2. Experimental procedures 
Acetyl-CoA, CoA (chromatographically pure) and 
CoA derivatives were obtained from P-L Biochemicals, 
Inc. This acetyl-CoA was identical kinetically to that 
prepared from acetic anhydride and CoA after puri- 
fication by DEAE-cellulose and Biogel P-2 chromato- 
graphy as described by C. Fung and M.F. Utter (per- 
sonal communication). The concentration was de- 
termined by assay with a-ketoglutarate dehydrogenase 
and phosphotransacetylase [ 14 ] . The succinyICoA 
was 90-92% pure, determined by assay with o-keto- 
acyl-CoA transferase and /I-hydroxybutyryl-CoA de- 
hydrogenase, and the absorbance at 258 nm. Succi- 
nyl-CoA, prepared from succinic anhydride and CoA 
[ 151 and chromatographed on DEAE-cellulose (for- 
mate form) according to Cha et al. [ 161, was used 
to verify the inhibition obtained with the commer- 
cial preparation. Propionyl-CoA was measured from 
the 2.58 nm absorbance using the specifications of 
P-L Biochemicals, Inc. The CoA content of the acyl- 
CoA derivatives, determined by assay with a-keto- 
glutarate dehydrogenase, was negligible. 
Citrate synthase was purified from beef heart 
and crystallized to a specific activity of 162 I.U. by 
the procedure of Srere [ 171. The same procedure, 
with slight modifications, was used to prepare the 
enzyme from rat liver mitochondria. 
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Table 1 
Kinetic parameters for the rate of oxalacetate utilization by citrate synthase. 
Enzyme 
source 
Inhibitor Ki 
(rM) 
Type with respect 
to acetyl-CoA 
Type with respect 
to oxalacetate 
Beef heart 
Beef heart 
Beef heart 
Beef heart 
Beef heart 
Rat liver 
ATP 950 
CoA 67 
SuccinylCoA 130 
Propionyl-CoA 50 
Citrate 1600 
Succinyl-CoA 140 
Mixed 
Mixed 
Competitive 
Competitive 
Noncompetitive 
Competitive 
Noncompetitive 
Noncompetitive 
Noncompetitive 
Noncompetitive 
Competitive 
Noncompetitive 
The K, for acetyl-CoA with the beef heart and rat liver enzymes were 8 and 10 PM, respectively. The K, for oxalacetate with 
the beef heart enzyme was 1.6 PM. 
The rate of citrate production was followed on a 
modified Eppendorf fluorometer with a coupled as- 
say system using NAD, malate and a large excess 
of malate dehydrogenase to produce equilibrium con- 
centrations of oxalacetate and NADH [2]. Full-scale 
deflection was obtained with 0.5 E.~M NADH over the 
range of l-20 PM NADH and initial velocities were 
measured using 20% of the scale. All reactions were 
performed in 0.1 M T&Cl, pH 7.4, 21” with 1 to 
10 X lo-’ mM citrate synthase. 
3. Results and discussion 
The kinetics of citrate production were examined 
with crystalline citrate synthase from beef heart. Va- 
riation of one substrate at a series of fixed levels of 
cosubstrate gave apparent Michaelis constants for 
acetyl-CoA and oxalacetate independent of the con- 
centration of cosubstrate. This finding is consistent 
with a mechanism of “rapid-equilibrium”, random 
addition of substrates as reported by Shepherd and 
Garland for the rat liver enzyme [2], and by Mori- 
yama and Srere [ 181 using the 5 ,S’-dithiobis-(2-nitro- 
benzoic acid) (DTNB) assay system. Over the range 
of acetyl-CoA concentrations (2- 100 PM) and oxal- 
acetate levels (l-10 PM) examined there was no evi- 
dence of substrate inhibition. Kinetic patterns and 
parameters are summarized in table 1. 
Care was taken to examine ATP inhibition at 
low concentrations of oxalacetate and under condi- 
tions where Shepherd and Garland [2] had observed 
an allosteric inhibition by ATP. The ATP concentra- 
tion used did not contribute significantly to the ionic 
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strength. In contrast to the work of Jangaard et al. 
[ 191 and Shepherd and Garland [2] , ATP variation 
introduced no signs of sigmoidicity into kinetic plots, 
and the inhibition was noncompetitive with respect 
to oxalacetate at all oxalacetate concentrations ex- 
amined (fig. 1). The absence of allosteric inhibition 
is consistent with physical studies of citrate synthase 
which report two identical subunits [ 18,201. Double 
reciprocal plots of acetyl-CoA varied at several fixed 
levels of ATP intersected on or slightly to the left of 
the ordinate, corresponding to about 50 PM acetyl- 
CoA. An identical kinetic pattern (mixed inhibition) 
and intersection point were obtained with CoA as an 
inhibitor (table 1). However, CoA inhibition has no 
parallel in intact rat heart mitochondria, where the 
directional changes of CoA and flux through citrate 
synthase are the same [ 12, 131. Since CoA inhibition 
is not strictly competitive with respect to acetyl-CoA, 
its strength relative to that of the inhibition by acyl- 
CoA derivatives may vary greatly with the conditions 
A Vor~aiton Of OAA 8 Vartatm Of AC COP, 
mM ATP MC CaA (,,M-‘) 
Fig. 1. Inhibition of beef heart citrate synthase by ATP in 
0.1 M TrisCI, pH 7.4, 2 1”. Velocities are expressed in arbi- 
trary units. 
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Fig. 2. Inhibition of citrate synthase by succinylCoA and 
propionyl-CoA in 0.1 M TrisCl, pH 7.4, 21”. Oxalacetate 
concentration, fixed by the malate dehydrogenase quili- 
brium, was 3.1 MM. 
used for kinetic measurements. Preliminary experi- 
ments varying ionic strength tend to support this 
conclusion. Alternatively, all the measured intrami- 
tochondrial CoA may not be fully accessible to ci- 
trate synthase at any given time. 
With the exception of succinyl-CoA, citrate is the 
strongest inhibitor among the citric acid cycle inter- 
mediates with a Ki of 1.6 mM. Citrate concentrations 
range at and above this level [ 131 and may provide 
an effective product inhibition at low oxalacetate con- 
centrations. cu-Ketoglutarate had a Ki greater than 
10 mM and was not competitive with respect to 
either substrate. 
Both succinyl-CoA and propionylCoA are competi- 
tive inhibitors with respect to acetyl-CoA and purely 
non-competitive with respect to oxalacetate (fig. 2). 
This is in marked contrast to the inhibition by palmi- 
toyl-CoA, once postulated to be a regulator of citrate 
synthase [21,22] and presently assumed to inhibit by 
a nonphysiological detergent-like action [23]. Palmi- 
toyl-CoA inhibition was not competitive with acetyl- 
CoA, but depended on the oxalacetate concentration, 
the ratio of enzyme to inhibitor, and the time of pre- 
incubation [23]. Inhibition of citrate synthase by 
propionyl-CoA or methylmalonyl-CoA may be im- 
portant under certain physiological conditions, and 
could explain the keto-acidosis and general meta- 
bolic disturbances observed in patients with an in- 
born defect of methylmalonyl-CoA mutase or with 
vitamin BrZ deficiency [24,25]. 
The suggestion has been made [2] that differences 
measured in kinetic parameters between rat liver and 
pig heart citrate synthase reflected differences in 
metabolic roles of the enzyme in liver and heart. A 
recent comparison shows, however, that the citrate 
synthase from rat heart and rat liver are immunologi- 
cally distinguishable and exhibit comparable inhibi- 
tion by ATP [ 181. The identity of the control fea- 
tures of the enzyme between tissues and species was 
supported by the fact that the K, for acetyl-CoA 
and the Ki for succinyl-CoA for the rat liver enzyme 
are identical to the respective parameters for the 
beef heart enzyme within the limits of experimental 
error (table 1). 
The present kinetic studies with purified citrate 
from beef heart and rat liver provide experimental 
proof for the postulate of coordination of citric acid 
cycle flux by alterations of the intramitochondrial 
succinyl-CoA content [ 121. Since succinyl-CoA 
levels are influenced by the intramitochondrial ATP/ 
ADP ratio via the phosphorylation state of the gua- 
nine nucleotides, feedback control to citrate syn- 
thase by succinyl-CoA will be strictly energy depen- 
dent. Although the Ki for succinyl-CoA (0.14 mM) 
is well below the reported range of mitochondrial 
succinyl-CoA concentrations, 0.3 to 1.4 mM [ 12, 131, 
the K, for acetyl-CoA (8 PM) is also much less than 
the intramitochondrial acetyl-CoA concentrations, 
0.1 to 1 .O mM [ 12- 141. These findings are consis- 
tent with the observation that the inhibition of citrate 
synthase by succinylCoA occurs only at low acetyl- 
CoA concentrations [ 121. Inhibition by succinyl- 
CoA, unlike that of ATP, is unaffected by Mg”. Be- 
cause of the high stability constant for the ATP-Mg 
complex [26], essentially all the ATP exists as this 
form at the molar ratios of Mg*+ to ATP greater than 
unity which prevail in the mitochondrial matrix [ 121. 
Regulation of citric acid cycle flux by a direct ATP 
inhibition of citrate synthase, therefore, would appear 
unlikely under physiological conditions. Inhibition 
of citrate synthase by succinyl-CoA rather than ATP 
probably accounts for the increased rate of keto- 
genesis observed by Krebs [27] upon addition of o- 
ketoglutarate to rat liver homogenates, and for the 
respiratory inhibitions observed with isolated rat 
liver and rat brain mitochondria after addition of 
ATP in the presence of oligomycin [3, 281. 
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